- Category: Products
- Tags: retina
Products
EVOQ Technologies receives US patent for mobile retinal function testing
Patent protection covers the SmartERG, a full-field ERG/VEP system that delivers visual stimulation and wirelessly records ocular electrophysiological responses.
Products
FDA approves Outlook's LYTENAVA for wet AMD
The VEGF inhibitor is now the first and only on-label ophthalmic formulation of bevacizumab for wet AMD treatment.
Products
Eyes On Eyecare launches retina research-based app
Cited for Retina offers a “PubMed meets Instagram Stories” way for retina specialists to discover, digest, and react to new research shaping their practice.
Products
Lumibird Medical launches wireless IntegreLIO system
First truly wireless integrated LIO enables unrestricted freedom of movement for physicians performing PRP and other peripheral retinal treatments.
Products
FDA approves Lupin's Lucentis biosimilar injection
Ranluspec (ranibizumab-hkdz) marks the third ranibizumab biosimilar cleared in the U.S. to treat five retinal indications.
Products
Remidio's portable fundus camera offers point-of-care imaging
FDA-cleared and smartphone-based diagnostic device offers complete imaging for both eyes in less than 1 minute—across a wide range of clinical settings.
Products
FDA clears Bausch + Lomb's Bi-Blade+ vitrectomy cutter and fluidics technology
Dual-port vitrectomy cutter increases cutting speed from 15K to 25K per minute, while Adaptive Fluidics update expands capabilities of the Stellaris Elite system
Products
Eyedaptic launches latest version of AI-based smart glasses for AMD
Designed for patients with retinal diseases, the EYE7 is an integrated wearable solution with real-time vision enhancements and a new visual assistant.
Products
Evoq launches FDA-registered dark adaptation testing device for IRDs
The Twilight is a wearable and smartphone-based diagnostic tool for at-home, remote monitoring of retinal health and early retinal disease detection.
Products
FDA approves new EYLEA HD indication, expanded dosing intervals
Intravitreally-administered 2 mg aflibercept therapeutic is now cleared for macular edema following retinal vein occlusion.Products
Regeneron receives FDA CRL, delaying Eylea HD sBLA approval
Company plans to resubmit app for pre-filled syringe version in early 2026, noting two 2025 dates to watch for.
Products
Optos unveils advanced Silverstone RGB UWF imaging system
Debuting at AAO, the ultra-widefield imaging platform delivers nine imaging modalities—the broadest spectrum of retinal imaging capabilities available for clinicians.
Products
FDA approves Celltrion's Eylea bisoimilar
EYDENZELT (aflibercept-bvoa) is indicated for patients with wet AMD, macular edema following RVO, DME, and DR.
Products
CMS assigns permanent J-code for Neurotech's ENCELTO cell therapy
The allogeneic encapsulated cell-based therapy is the first and only treatment approved by the FDA for the treatment of MacTel.
Products
Essilor introduces Cellview Retinal Camera with widefield fundus imaging
Easy-to-use retinal imager makes its Essilor debut at Vision Expo West over 6 months after its acquisition.
Products
Optos and Toku partner to add AI-based 'BioAge' to UWF imaging
Non-invasive retinal scan estimates a patient’s biologic age by analyzing biometric markers within the retina—now using Optos’ UWF imaging devices.
Products
identifeye HEALTH launches AI-based retinal screening platform
The FDA-registered, compact, app-based portable system is designed to detect early signs of ocular and systemic disease in point-of-care settings.
Products
Clinicians perform first FDA-approved ENCELTO treatment for MacTel
As the first-ever FDA-approved MacTel therapy, ENCELTO (revakinagene taroretcel-lwey) is a single-dose ocular implant administered via an outpatient vitreoretinal surgery.
Products
Optomed USA launches next-gen handheld fundus camera
MedTech company’s Optomed Lumo is a portable, non-mydriatic retinal camera designed for “flexibility and ease of use” in a variety of healthcare settings
Products